15-keto Latanoprost |
A potential metabolite of latanoprost when administered to animals |
10 mg |
16816-10 |
More Info
|
15-keto Latanoprost |
A potential metabolite of latanoprost when administered to animals |
5 mg |
16816-5 |
More Info
|
9-keto Latanoprost |
A derivative of latanoprost |
1 mg |
9000350-1 |
More Info
|
9-keto Latanoprost |
A derivative of latanoprost |
10 mg |
9000350-10 |
More Info
|
9-keto Latanoprost |
A derivative of latanoprost |
5 mg |
9000350-5 |
More Info
|
15-keto Latanoprost (free acid) |
A potential metabolite of latanoprost when administered to animals; common… |
1 mg |
16815-1 |
More Info
|
15-keto Latanoprost (free acid) |
A potential metabolite of latanoprost when administered to animals; common… |
10 mg |
16815-10 |
More Info
|
15-keto Latanoprost (free acid) |
A potential metabolite of latanoprost when administered to animals; common… |
5 mg |
16815-5 |
More Info
|
12-keto Lithocholic Acid |
A metabolite of DCA; fecal levels are elevated in rats fed a diet suppleme… |
10 mg |
29547-10 |
More Info
|
12-keto Lithocholic Acid |
A metabolite of DCA; fecal levels are elevated in rats fed a diet suppleme… |
25 mg |
29547-25 |
More Info
|
12-keto Lithocholic Acid |
A metabolite of DCA; fecal levels are elevated in rats fed a diet suppleme… |
5 mg |
29547-5 |
More Info
|
12-keto Lithocholic Acid |
A metabolite of DCA; fecal levels are elevated in rats fed a diet suppleme… |
50 mg |
29547-50 |
More Info
|
6-keto Lithocholic Acid |
A metabolite of lithocholic acid |
10 mg |
35373-10 |
More Info
|
7-keto Lithocholic Acid |
An intermediate in the synthesis of ursodeoxycholic acid by intestinal bac… |
1 g |
29546-1 |
More Info
|
7-keto Lithocholic Acid |
An intermediate in the synthesis of ursodeoxycholic acid by intestinal bac… |
10 g |
29546-10 |
More Info
|
7-keto Lithocholic Acid |
An intermediate in the synthesis of ursodeoxycholic acid by intestinal bac… |
5 g |
29546-5 |
More Info
|
7-keto Lithocholic Acid |
An intermediate in the synthesis of ursodeoxycholic acid by intestinal bac… |
500 mg |
29546-500 |
More Info
|
10-keto Naltrexone |
An antagonist of μ-, κ-, and δ-opioid receptors (Kis = 31.1… |
1 mg |
40441-1 |
More Info
|
10-keto Naltrexone |
An antagonist of μ-, κ-, and δ-opioid receptors (Kis = 31.1… |
10 mg |
40441-10 |
More Info
|
10-keto Naltrexone |
An antagonist of μ-, κ-, and δ-opioid receptors (Kis = 31.1… |
25 mg |
40441-25 |
More Info
|
10-keto Naltrexone |
An antagonist of μ-, κ-, and δ-opioid receptors (Kis = 31.1… |
5 mg |
40441-5 |
More Info
|
3-keto Petromyzonol |
A synthetic intermediate useful for pharmaceutical synthesis. |
1 mg |
10007055-1 |
More Info
|
3-keto Petromyzonol |
A synthetic intermediate useful for pharmaceutical synthesis. |
10 mg |
10007055-10 |
More Info
|
3-keto Petromyzonol |
A synthetic intermediate useful for pharmaceutical synthesis. |
5 mg |
10007055-5 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α |
A potential metabolite of bimatoprost when administered to animals; potent… |
1 mg |
16817-1 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α |
A potential metabolite of bimatoprost when administered to animals; potent… |
10 mg |
16817-10 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α |
A potential metabolite of bimatoprost when administered to animals; potent… |
5 mg |
16817-5 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide |
A potential metabolite of bimatoprost |
1 mg |
10010405-1 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide |
A potential metabolite of bimatoprost |
10 mg |
10010405-10 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide |
A potential metabolite of bimatoprost |
25 mg |
10010405-25 |
More Info
|
15-keto-17-phenyl trinor Prostaglandin F2α ethyl amide |
A potential metabolite of bimatoprost |
5 mg |
10010405-5 |
More Info
|
15-keto Prostaglandin A1 |
A potential metabolite of PGA1, produced by 15-hydroxy PGDH; causes vasoco… |
1 mg |
9000142-1 |
More Info
|
15-keto Prostaglandin A1 |
A potential metabolite of PGA1, produced by 15-hydroxy PGDH; causes vasoco… |
5 mg |
9000142-5 |
More Info
|
15-keto Prostaglandin A1 |
A potential metabolite of PGA1, produced by 15-hydroxy PGDH; causes vasoco… |
500 µg |
9000142-500 |
More Info
|
15-keto Prostaglandin E1 |
15-keto PGE1 is the inactive metabolite of PGE1 produced by 15-hydroxy PGD… |
1 mg |
13680-1 |
More Info
|
15-keto Prostaglandin E1 |
15-keto PGE1 is the inactive metabolite of PGE1 produced by 15-hydroxy PGD… |
10 mg |
13680-10 |
More Info
|
15-keto Prostaglandin E1 |
15-keto PGE1 is the inactive metabolite of PGE1 produced by 15-hydroxy PGD… |
5 mg |
13680-5 |
More Info
|
15-keto Prostaglandin E1 |
15-keto PGE1 is the inactive metabolite of PGE1 produced by 15-hydroxy PGD… |
500 µg |
13680-500 |
More Info
|
15-keto Prostaglandin E2 |
A metabolite of PGE2; does not bind effectively to the PGE2 receptors EP2… |
1 mg |
14720-1 |
More Info
|
15-keto Prostaglandin E2 |
A metabolite of PGE2; does not bind effectively to the PGE2 receptors EP2… |
10 mg |
14720-10 |
More Info
|
15-keto Prostaglandin E2 |
A metabolite of PGE2; does not bind effectively to the PGE2 receptors EP2… |
5 mg |
14720-5 |
More Info
|
15-keto Prostaglandin E2 |
A metabolite of PGE2; does not bind effectively to the PGE2 receptors EP2… |
500 µg |
14720-500 |
More Info
|
6-keto Prostaglandin E1 |
6-keto PGE1 is a metabolite isolated after the incubation of PGI2 with rab… |
1 mg |
13260-1 |
More Info
|
6-keto Prostaglandin E1 |
6-keto PGE1 is a metabolite isolated after the incubation of PGI2 with rab… |
100 µg |
13260-100 |
More Info
|
6-keto Prostaglandin E1 |
6-keto PGE1 is a metabolite isolated after the incubation of PGI2 with rab… |
500 µg |
13260-500 |
More Info
|
15-keto Prostaglandin E2-d4 |
An internal standard for the quantification of 15-keto PGE2 by GC- or LC-MS |
100 µg |
19349-100 |
More Info
|
15-keto Prostaglandin E2-d4 |
An internal standard for the quantification of 15-keto PGE2 by GC- or LC-MS |
50 µg |
19349-50 |
More Info
|
15-keto Prostaglandin E2-d9 |
An internal standard for the quantification of 15-keto PGE2 by GC- or LC-MS |
100 µg |
19350-100 |
More Info
|
15-keto Prostaglandin E2-d9 |
An internal standard for the quantification of 15-keto PGE2 by GC- or LC-MS |
50 µg |
19350-50 |
More Info
|
15-keto Prostaglandin F1α |
15-keto PGF1α is the initial metabolite of PGF1α via 15-hydrox… |
1 mg |
15710-1 |
More Info
|
15-keto Prostaglandin F1α |
15-keto PGF1α is the initial metabolite of PGF1α via 15-hydrox… |
10 mg |
15710-10 |
More Info
|
15-keto Prostaglandin F1α |
15-keto PGF1α is the initial metabolite of PGF1α via 15-hydrox… |
5 mg |
15710-5 |
More Info
|
15-keto Prostaglandin F2α |
First metabolite of PGF2α in the 15-hydroxy PGDH pathway; a critical… |
1 mg |
16720-1 |
More Info
|
15-keto Prostaglandin F2α |
First metabolite of PGF2α in the 15-hydroxy PGDH pathway; a critical… |
10 mg |
16720-10 |
More Info
|
15-keto Prostaglandin F2α |
First metabolite of PGF2α in the 15-hydroxy PGDH pathway; a critical… |
5 mg |
16720-5 |
More Info
|
6-keto Prostaglandin F1α |
The inactive, non-enzymatic hydrolysis product of PGI2, |
1 mg |
15210-1 |
More Info
|
6-keto Prostaglandin F1α |
The inactive, non-enzymatic hydrolysis product of PGI2, |
10 mg |
15210-10 |
More Info
|
6-keto Prostaglandin F1α |
The inactive, non-enzymatic hydrolysis product of PGI2, |
5 mg |
15210-5 |
More Info
|
6-keto Prostaglandin F1α-d4 |
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' position… |
1 mg |
315210-1 |
More Info
|
6-keto Prostaglandin F1α-d4 |
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' position… |
100 µg |
315210-100 |
More Info
|
6-keto Prostaglandin F1α-d4 |
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' position… |
25 µg |
315210-25 |
More Info
|
6-keto Prostaglandin F1α-d4 |
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' position… |
50 µg |
315210-50 |
More Info
|
6-keto Prostaglandin F1α ELISA Kit |
Prostacyclin is formed from arachidonic acid primarily by the vascular end… |
480 Solid |
515211-480SOLIDWELLS |
More Info
|
6-keto Prostaglandin F1α ELISA Kit |
Prostacyclin is formed from arachidonic acid primarily by the vascular end… |
480 Well |
515211-480STRIPWELLS |
More Info
|
6-keto Prostaglandin F1α ELISA Kit |
Prostacyclin is formed from arachidonic acid primarily by the vascular end… |
96 Solid |
515211-96SOLIDWELLS |
More Info
|
6-keto Prostaglandin F1α ELISA Kit |
Prostacyclin is formed from arachidonic acid primarily by the vascular end… |
96 Well |
515211-96STRIPWELLS |
More Info
|
6-keto Prostaglandin F1α Quant-PAK |
The 6-keto PGF1α Quant-PAK has been designed for the convenient, pre… |
1 ea |
10006830-1EA |
More Info
|
Ketorolac |
An NSAID and COX inhibitor (IC50s = 20 nM for both COX-1 and COX-2); preve… |
1 g |
9001148-1 |
More Info
|
Ketorolac |
An NSAID and COX inhibitor (IC50s = 20 nM for both COX-1 and COX-2); preve… |
100 mg |
9001148-100 |
More Info
|
Ketorolac |
An NSAID and COX inhibitor (IC50s = 20 nM for both COX-1 and COX-2); preve… |
50 mg |
9001148-50 |
More Info
|
Ketorolac |
An NSAID and COX inhibitor (IC50s = 20 nM for both COX-1 and COX-2); preve… |
500 mg |
9001148-500 |
More Info
|
Ketorolac (calcium salt) |
An NSAID and COX inhibitor (IC50 = 20 nM for both COX-1 and COX-2); preven… |
1 g |
9003475-1 |
More Info
|
Ketorolac (calcium salt) |
An NSAID and COX inhibitor (IC50 = 20 nM for both COX-1 and COX-2); preven… |
100 mg |
9003475-100 |
More Info
|
Ketorolac (calcium salt) |
An NSAID and COX inhibitor (IC50 = 20 nM for both COX-1 and COX-2); preven… |
250 mg |
9003475-250 |
More Info
|
Ketorolac (calcium salt) |
An NSAID and COX inhibitor (IC50 = 20 nM for both COX-1 and COX-2); preven… |
500 mg |
9003475-500 |
More Info
|